CDC Identifies Contamination in More Medical Products From New England Compounding Center
The CDC has identified additional microbial contamination in unopened vials of betamethasone, cardioplegia and triamcinolone solutions that were distributed and recalled from NECC.
Clinicians should continue to report infections related to NECC products to FDA's MedWatch and state health departments.
Related Articles on ASC Medical Supplies:
Access MediQuip Names Patrick McCarthy Chief Network Development Officer
Volcano Corp. to Acquire Crux Biomedical
FDA Enters Partnership to Help Increase Access to New Medical Devices
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Castle Connolly recognizes Dr. Semih Gungor as a top NY doctor: 4 things to know
- Penn State researchers develop care plan for Crohn's disease complications: 5 insights
- Study finds dietary fiber may reduce IBD flares: 5 insights
- Latest payer ACA departures further limit consumers' options — 5 takeaways
- Physicians Endoscopy appoints Guidon Partners Founder Greg Roth to board of directors following Kelso deal: 4 highlights